Leucine Rich Repeat Containing Protein 32 (LRRC32) Antibody (PE)

689€ (100 tests)
Este producto es parte de LRRC - Leucine-rich repeat-containing protein
Product Graph
689€ (100 tests)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
Leucine Rich Repeat Containing Protein 32 (LRRC32) Antibody (PE)
category
Primary Antibodies
provider
Abbexa
reference
abx270984
tested applications
FCM

Descripción del producto

Leucine Rich Repeat Containing Protein 32 (LRRC32) Antibody (PE) is a Rabbit Polyclonal Antibody conjugated to PE against Leucine Rich Repeat Containing Protein 32 (LRRC32) for use in flow cytometry.

Documents del producto

Instrucciones
Data sheet
Descargar

Especificaciones del producto

AliasGarpin,Transforming growth factor beta activator LRRC32,Glycoprotein A repetitions predominant,D11S833E
AvailabilityPlease enquire.
BackgroundAntibody anti-LRRC32
Buffer0.01 M PBS, pH 7.4, containing 0.05% Proclin-300, 50% glycerol.
CategoryPrimary Antibodies
ClonalityPolyclonal
ConjugationPE
Dry IceNo
FormLiquid
HostRabbit
Immunogen TargetLeucine Rich Repeat Containing Protein 32 (LRRC32)
IsotypeIgG
NameLeucine Rich Repeat Containing Protein 32 (LRRC32) Antibody (PE)
Price689
ProviderAbbexa
PurificationPurified by antigen-specific affinity chromatography.
ReactivityRat
Recommended DilutionFCM: 1-5 µl/106 cells. Optimal dilutions/concentrations should be determined by the end user.
Referenceabx270984
Size 1100 tests
Size 2200 tests
Size 3500 tests
StatusRUO
StorageAliquot and store at 2°C to 8°C upon receipt. Avoid exposure to light.
Tested ApplicationsFCM

Descripcion del producto en español

Background en español

LRRC32, also known as glycoprotein A repetitions predominant (GARP), is a membrane protein highly expressed on regulatory T cells (Tregs) and platelets where it plays a critical role in regulating immune tolerance it acts as a receptor for latent TGF-β (transforming growth factor-beta) facilitating its activation and release on the cell surface LRRC32 is crucial for maintaining Treg function and suppressing excessive immune responses studies indicate its involvement in autoimmunity cancer and inflammation where dysregulation of LRRC32-mediated TGF-β signaling contributes to disease progression its role in tumor immunity is particularly notable as it enables tumors to evade immune surveillance by promoting an immunosuppressive microenvironment ongoing research is focused on targeting LRRC32 to modulate Treg activity in diseases such as cancer and autoimmune disorders making it a promising therapeutic candidate

Related Products

abx067753

Mouse Leucine Rich Repeat Containing Protein 32 (LRRC32) Protein

Recombinant Leucine Rich Repeat Containing Protein 32 (LRRC32) is a recombinant Mouse protein produced in a Prokaryotic expression system (E. coli).

Ver Producto
abx104289

Leucine Rich Repeat Containing Protein 32 (LRRC32) Antibody

Polyclonal Antibody to Leucine Rich Repeat Containing Protein 32 (LRRC32).

Ver Producto
abx130377

Leucine Rich Repeat Containing Protein 32 (LRRC32) Antibody

Leucine Rich Repeat Containing Protein 32 Antibody is a Rabbit Polyclonal against Leucine Rich Repeat Containing Protein 32.

Ver Producto